This invention relates to a humanized antibody that neutralizes RSV and that has at least one non-human heavy chain CDR and at least one non-human light chain CDR of the heavy chain CDRs of MEDI-493 of Figure 7 and the light chain CDRs of MEDI-493 of Figure 8.